Skip to main content
Hawk
SuperLineage
About Us
Careers
Resources
Contact Us
Go Back
RWD Clinical Trials
Explore how RWD clinical trials leveraging approaches such as external control arms, hybrid controls, pragmatic elements, and covariate adjustment are reducing timelines, costs, and patient burdens.
Hybrid controls
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer
Paper
Read more
ECA
External control arms in oncology: current use and future directions
Review Article
Read more
Covariate Adjustment
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance
Read more
Hybrid controls
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
Paper
Read more
ECA
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Review Article
Read more
Registry RCTs
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
Paper
Read more
Covariate Adjustment
Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score
Paper
Read more
Registry RCTs
Registry randomised trials: a methodological perspective
Review Article
Read more
Show More